Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

Rheumatology & Arthritis Learning Network
17/08/2023 16 min
Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs

Listen "Matthew Baker, MD, on Interstitial Lung Disease Among Patients With RA Treated with DMARDs"

Descargar episodio Ver en sitio original

Episode Synopsis

Dr Baker reviews the findings of his recent research into the association of interstitial lung disease among patients with rheumatoid arthritis who have been treated with both biologic and targeted disease-modifying antirheumatic drugs.

More episodes of the podcast Rheumatology & Arthritis Learning Network

Dacre Knight, MD, on Hypermobility Syndromes 28/04/2025
Leonard Calabrese, DO, on Long COVID 01/01/2025
Misti Paudel, PhD, on Difficult-to-Treat Rheumatoid Arthritis 06/08/2024
Vikas Majithia, MD, and Ronald Butendieck, MD, on the Continuing Challenges of Gout 19/06/2024
Risk Factors for COVID-19 Reinfection Among Patients With Rheumatic Diseases 13/03/2024
Neal Birnbaum, MD, on the new CMS Rule on Prior Authorization 28/02/2024
Leonard Calabrese, DO, on the Nosology of Long COVID 21/02/2024
Elena Myasoedova, MD, PhD, on Extra-articular Manifestations of RA 20/11/2023
Roy Fleischmann, MD, on the Safety Profile of Upadacitinib In Patients With RA 07/11/2023
Matthew Baker, MD, on the Association of Osteoarthritis With Atopic Dermatitis 01/11/2023
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA